Literature DB >> 21219880

The food colorant erythrosine is a promiscuous protein-protein interaction inhibitor.

Lakshmi Ganesan1, Emilio Margolles-Clark, Yun Song, Peter Buchwald.   

Abstract

Following our observation that erythrosine B (FD&C Red No. 3) is a relatively potent inhibitor of the TNF-R-TNFα and CD40-CD154 protein-protein interactions, we investigated whether this inhibitory activity extends to any other protein-protein interactions (PPI) as well as whether any other approved food colors possess such inhibitory activity. We found erythrosine, a poly-iodinated xanthene dye, to be a non-specific promiscuous inhibitor of a number of PPIs within the tumor necrosis factor superfamily (TNF-R-TNFα, CD40-CD154, BAFF-R-BAFF, RANK-RANKL, OX40-OX40L, 4-1BB-4-1BBL) as well as outside of it (EGF-R-EGF) with a remarkably consistent median inhibitory concentration (IC(50)) in the 2-20 μM (approximately 2-20mg/L) range. In agreement with this, erythrosine also showed cellular effects including clear cytotoxic effects around this concentration range (IC₅₀≈50 μM). Among the seven FDA-approved food colorants, only erythrosine showed consistent PPI inhibitory activity in the sub-100 μM range, which might also explain (at least partially) why it also has the lowest approved acceptable daily intake (ADI) (0.1 mg/kg body weight/day). Among a number of xanthene structural analogs of erythrosine tested for activity, rose Bengal, a food colorant approved in Japan, showed similar, maybe even more pronounced, promiscuous inhibitory activity, whereas fluorescein was inactive and gallein, phloxine, and eosin were somewhat active in some of the assays.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21219880     DOI: 10.1016/j.bcp.2010.12.020

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  15 in total

Review 1.  Toward Small-Molecule Inhibition of Protein-Protein Interactions: General Aspects and Recent Progress in Targeting Costimulatory and Coinhibitory (Immune Checkpoint) Interactions.

Authors:  Damir Bojadzic; Peter Buchwald
Journal:  Curr Top Med Chem       Date:  2018       Impact factor: 3.295

2.  Small-molecule modulators of the OX40-OX40 ligand co-stimulatory protein-protein interaction.

Authors:  Yun Song; Emilio Margolles-Clark; Allison Bayer; Peter Buchwald
Journal:  Br J Pharmacol       Date:  2014-11       Impact factor: 8.739

3.  CD40-targeting KGYY15 peptides do not efficiently block the CD40-CD40L interaction.

Authors:  Damir Bojadzic; Peter Buchwald
Journal:  Diabetologia       Date:  2019-09-09       Impact factor: 10.122

4.  Small molecule inhibition of the TNF family cytokine CD40 ligand through a subunit fracture mechanism.

Authors:  Laura F Silvian; Jessica E Friedman; Kathy Strauch; Teresa G Cachero; Eric S Day; Fang Qian; Brian Cunningham; Amy Fung; Lihong Sun; Gerald W Shipps; Lihe Su; Zhongli Zheng; Gnanasambandam Kumaravel; Adrian Whitty
Journal:  ACS Chem Biol       Date:  2011-04-20       Impact factor: 5.100

Review 5.  TNF superfamily protein-protein interactions: feasibility of small- molecule modulation.

Authors:  Yun Song; Peter Buchwald
Journal:  Curr Drug Targets       Date:  2015       Impact factor: 3.465

6.  A study of the control of oral plaque biofilms via antibacterial photodynamic therapy.

Authors:  J F Tahmassebi; E Drogkari; S R Wood
Journal:  Eur Arch Paediatr Dent       Date:  2015-09-18

7.  The promiscuous protein binding ability of erythrosine B studied by metachromasy (metachromasia).

Authors:  Lakshmi Ganesan; Peter Buchwald
Journal:  J Mol Recognit       Date:  2013-04       Impact factor: 2.137

8.  Effects of representative glucocorticoids on TNFα- and CD40L-induced NF-κB activation in sensor cells.

Authors:  Sirlene R Cechin; Peter Buchwald
Journal:  Steroids       Date:  2014-04-18       Impact factor: 2.668

9.  In silico and crystallographic studies identify key structural features of biliverdin IXβ reductase inhibitors having nanomolar potency.

Authors:  Natasha M Nesbitt; Xiliang Zheng; Zongdong Li; José A Manso; Wan-Yi Yen; Lisa E Malone; Jorge Ripoll-Rozada; Pedro José Barbosa Pereira; Timothy J Mantle; Jin Wang; Wadie F Bahou
Journal:  J Biol Chem       Date:  2018-02-27       Impact factor: 5.157

10.  Small-Molecule Inhibitors of the CD40-CD40L Costimulatory Protein-Protein Interaction.

Authors:  Jinshui Chen; Yun Song; Damir Bojadzic; Alejandro Tamayo-Garcia; Ana Marie Landin; Bonnie B Blomberg; Peter Buchwald
Journal:  J Med Chem       Date:  2017-10-25       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.